Last updated: 2025-12-12 09:42:30 ET
Enough is enough
The drugmaker is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill...
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any...
Eli Lilly’s “triple g” drug helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis i...
Rocketeer's new Keiryo Miata has 375 horsepower and a 1,900-pound curb weight.
The bank upgraded shares of the telecommunications company to overweight from equal-weight.
Chinese AI startup Zhipu AI aka Z.ai has released its GLM-4.6V series, a new generation of open-source vision-language models (VLMs) optimized for mul...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron, that just showed positive results from a Phase 2 trial.
The analyst downgraded Tesla's stock to equal weight from overweight.
